Purpose: To study peripapillary choroidal thickness (PPCT) around the optic disc and establish zones using a new swept source optical coherence tomography (SS-OCT) device. To evaluate PPCT differences between patients with multiple sclerosis (MS) and age-and sex-matched healthy controls. Methods: A total of 102 healthy subjects and 51 patients with MS were consecutively recruited. Healthy subjects were divided into teaching (n = 51, used to establish choroidal zones) and validating (n = 51, used to compare measurements with MS patients) populations. An optic disc 6.0 3 6.0-mm three-dimensional scan was obtained using SS-OCT Triton. A 26 3 26 cube-grid centred on the optic disc was generated automatically to measure PPCT. Four choroidal zones were established and used to compare PPCT between healthy controls and patients with MS. Results: Peripapillary choroidal thickness (PPCT) was significantly thinner in patients in all concentric zones (p ≤ 0.0001): 134.02 AE 16.59 lm in MS group versus 171.56 AE 12.43 lm in the control group in zone 2; 182.23 AE 20.52 versus 219.03 AE 17.99 lm, respectively, in zone 3; and 223.52 AE 10.70 versus 259.99 AE 10.29 lm, respectively, in zone 4. The choroidal thinning in the MS group tended to decrease as we distanced from the optic nerve head. Peripapillary choroidal thickness (PPCT) had a similar pattern in controls and MS; it was thicker in the superior region, followed by temporal, nasal and inferior regions. Conclusion: Patients with MS showed peripapillary choroidal thinning when compared with healthy subjects in all zones around the optic disc. Peripapillary choroidal tissue shows a concentric pattern, increasing in thickness when increasing the distance from the optic nerve. The new SS-OCT could be useful for evaluating choroidal thinning in clinical practice.
Introduction
Multiple sclerosis (MS) is an autoimmune-mediated disease of the central nervous system with a multifactorial pathogenesis. Recent models support the presence of three related mechanisms: inflammation, demyelination and neurodegeneration, in MS (Garcia-Martin et al. 2011) . MartinezLapiscina et al. (2016) ; Fisher et al. (2006) reported a correlation between axonal loss in the optic nerve of patients with MS and the extent of functional disability. Several mechanisms by which axonal loss caused by MS could lead to tissue degeneration and ultrastructural changes of the retinal ganglionar cells, astrocytes and endothelial cells have been proposed by Zeis et al. (2008) , but changes of the choroidal layer have not been evaluated.
Cells and tissues can deform in various ways, such as extension, compression, demyelination, atrophy or shearing, and these modes of alteration are not independent from each other. The mechanobiologic response of tissues (Edwards et al. 2001 ) and cells (Pedersen & Swartz 2005 ) depends on the mode of deformation, as well as the magnitude and temporal profile of the stimulus, and the type of tissue or cell and its biological state. It would therefore be interesting to evaluate potential deformations of each tissue type and ocular layer in patients with MS.
Until OCT was developed, choroidal studies were limited to histopathologic analyses. Although OCT can provide important information about the choroid, the role of choroidal analysis for ocular pathologies is controversial.
Several studies using spectral domain optical coherence tomography (SD-OCT), mostly with enhanced depth imaging (EDI), evaluated macular and peripapillary choroid, mainly in healthy eyes and glaucoma patients, (Banitt 2013; Abegão Pinto et al. 2016 ), yet the peripapillary choroid results are inconsistent. Some authors reported a reduced mean or regional peripapillary choroidal thickness (PPCT) in patients with primary open-angle glaucoma, often associated with sclerotic optic disc damage (Hirooka et al. 2012; Roberts et al. 2012; Usui et al. 2012) . Other studies reported no differences in PPCT between glaucoma and healthy eyes (Ehrlich et al. 2011; Maul et al. 2011) . Most of these studies, however, had important limitations: First, the authors used manual measurements of choroidal thickness using the SD-OCT at a few points and beneath the circumpapillary ring, which is typically used to evaluate the retinal nerve fibre layer (RNFL). Second, the choroid is a highly vascularized and partially irregular tissue, so the sampling of a few choroidal measurements may not adequately reveal the whole dimension of this tissue. In contrast, the automated segmental measurement software used in this study provides a broader and more objective evaluation of choroidal thickness.
Swept source optical coherence tomography (SS-OCT), as compared with SD-OCT with EDI, provides better visualization of the choroid (Adhi et al. 2014) , more accurately obtains deep tissue measurements, better detects the posterior limit of the sclera (Park et al. 2014) , and can evaluate a broader region of the posterior segment.
Given the ability of this new SS-OCT technology to better visualize and measure automatically a wide area of peripapillary choroid, our first objective was to measure the PPCT in a 26 9 26 cube-grid, which can be automatically performed using the DRI-OCT Triton (Topcon Corporation, Tokyo, Japan), in a sample of healthy subjects to evaluate the distribution of PPCT and to establish objective zones with similar PPCT. Our second objective was to study differences in the PPCT within these zones between a sample of patients with MS and ageand sex-matched healthy controls. To the best of our knowledge, there has been no thorough investigation of the quantitative differences between normal and patients with MS using automatically choroidal measurements. The main advantage of this study is that the PPCT was evaluated not only at a few points or beneath the circumpapillary ring using manual procedures, but also in a wide area of the peripapillary choroid using a new automatic and accurate method.
Material and Methods

Study population and design
This prospective case-control study included patients with definite relapsing-remitting MS and age-and sexmatched healthy controls seen at a single institution. A total of 51 eyes of 51 patients with MS and 102 eyes of 102 healthy controls were evaluated. Multiple sclerosis (MS) was diagnosed based on the revised McDonald Criteria and confirmed by a neurologist specializing in MS (Polman et al. 2011) . Patients with a visual acuity inferior to 0.1 in Snellen scale (or 20/ 200 or 6/60), intraocular pressure > 20 mmHg, antecedent optic neuritis, and/or active MS flare (of any neurologic deficit) in the 6 months preceding enrolment into the study were excluded from the study. Patients with refractive errors >5 dioptres of spherical equivalent refraction or 3 dioptres of astigmatism were also excluded from the study.
Standard protocol approval, registration, and patient consent
The study procedures were performed in accordance with the tenets of the Declaration of Helsinki, and the local ethics committee approved the study protocol. Written informed consent to participate in the study was obtained from all subjects.
Main outcome measures
To determine choroidal thickness in healthy controls measured by automated software of SS-OCT, to define areas with similar choroidal thickness, to measure these areas in patients with MS and compare them with healthy controls.
Methodology
A complete neuro-ophthalmic examination, including assessment of bestcorrected visual acuity using the Snellen chart, assessment of visual field using Humphrey Field Analyzer (Carl-Zeiss Meditec, Dublin, CA, USA) with a SITA Standard strategy (programme 30-2), pupillary reflexes, and ocular motility; examinations of the anterior segment, intraocular pressure with the Goldmann applanation tonometer, and papillary morphology by funduscopic exam; as well as OCT. In addition, the Expanded Disability Status Scale (EDSS) score, the visual EDSS, and disease duration were recorded for the MS group.
OCT
An optic disc 6.0 9 6.0 mm threedimensional scan was obtained using the Deep Range Imaging (DRI) OCT Triton (Topcon Corporation, Tokyo, Japan). This scan combines morphometric optic disc parameters and various peripapillary parameters, including RNFL and choroidal thickness. The subjects were seated and properly positioned. All DRI-OCT images were obtained by a single and well-trained technician. The DRI-OCT Triton includes the new SMART-Track TM tool (Topcon Corporation, Tokyo, Japan) that enhances the tracking, corrects motion and guides the operator to reduce potential errors while acquiring the images. Patients were not dilated. Only eyes with good-quality scans were included in the analysis. Good-quality SS-OCT images were defined as those with a signal strength ≥40 (maximum = 100), and without motion artefact, involuntary saccades or overt misalignment or decentration. Two eyes (one from each group) were excluded due to poor DRI-OCT image quality; therefore, one additional subject was added to each group.
A 26 9 26 cube-grid centred in the optic disc was generated to automatically measure choroidal thickness. This grid included 676 cubes (200 9 200 lm 9 PPCT) around the optic nerve head, but the 88 central cubes corresponding to the optic nerve head area were not analyzed; so the DRI-OCT Triton measured the choroidal thickness for a total of 588 peripapillary cubes (Fig. 1) . The delimitation of the optic nerve and the central cubes is automatically performed by the OCT software (Topcon Corporation, Tokyo, Japan). The Bruch membrane and choroidal-scleral interface were delineated using the segmentation algorithm implemented by Topcon (Fig. 2) .
We analyzed a total of 153 eyes: 102 healthy controls and 51 patients with MS. The healthy control group was divided into two populations: the teaching population (n = 51 controls, used to establish choroidal zones) and the validating population (n = 51 controls, used to compare measurements with MS patients). The populations did not differ from the MS group concerning age and sex. Only right eyes were selected for the statistical analysis, because some authors have reported differences in the choroidal thickness between right and left eyes (Spaide et al. 2008; Chen et al. 2012 ).
Statistical analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS 20.0, SPSS Inc., Chicago, IL, USA). The KolmogorovSmirnov test was used to assess sample distribution of the variables. For quantitative data following a parametric distribution, differences between groups were compared using the Student t-test. For qualitative data, a chisquare test was used for comparison. A p-value of <0.05 was considered statistically significant.
Results
Visual function tests presented significantly worse results in MS group compared with control group: 0.14 AE 0.21 versus 0.02 AE 0.19 for best-corrected visual acuity (p = 0.004), and À1.98 AE 2.06 and À1.21 AE 1.55 dB for mean deviation of the visual field (p = 0.002). Mean EDSS score was 0.9 AE 0.01 in MS group.
Teaching population evaluation to establish peripapillary choroidal zones
The teaching population, comprising 51 right eyes from healthy subjects, was used to define 4 choroidal zones. The mean age of this population was 52.34 AE 12.33 years (range, 20-75 years) . Of the 51 subjects, 14 (27%) were male. Mean spherical equivalent was 0.13 AE 1.49 D.
The study zones were previously established, regarding the thickness of the cubes in each acquisition point. Zone 1 corresponded to the optic nerve head area, thus it was not measured by the OCT and was not incorporated into the study. Zone 2 contained cubes with a choroidal thickness between 120 and 179 lm, zone 3 contained cubes with a choroidal thickness between 180 and 239 lm, and zone 4 contained cubes with a thickness of 240 lm or more (Fig. 1B) .
Mean choroidal thickness in zone 2 was 160.74 AE 12.43 lm and included 199 cubes of the choroidal grid; zone 3 had a mean thickness of 208.80 AE 18.08 lm and included 327 cubes; and mean thickness in zone 4 was 251.74 AE 10.78 lm and included 62 cubes (Fig. 1B) . Figure 3 shows the four zones in the teaching population of healthy controls that are roughly concentric to the optic nerve head; zone 2 (the thinnest of the study zones with a minimum mean PPCT of 127.08 lm) mainly located the nearest to the optic nerve head and inferior peripapillary choroid; zone 3 mainly located in the superior, temporal and nasal peripapillary choroid; and zone 4 (the thickest with a maximum mean PPCT of 281.52 lm), corresponding to the most distal cubes, mainly located in the superior and temporal peripapillary choroid.
Validating population and statistical comparison between healthy and ms eyes
Once the study zones were established, a statistical comparison between control and MS eyes was performed on a different population. A total of 51 right eyes from healthy subjects (independent from those subjects used in the teaching population) and 51 right eyes from patients with MS were included in the study. The mean age of the healthy control group was 51.93 AE 9.37 years (range: 21-78 years) and the mean age of the MS group was 51.95 AE 10.09 years (range: 20-74 years). Of the 51 subjects, 14 (27.45%) were men. Mean spherical equivalent was 0.15 AE 2.01 D in the control group and 0.11 AE 1.32 D in the MS group. Age, sex and spherical equivalent were not statistically different between groups (p < 0.05). The population characteristics of the study are summarized in Table 1 .
Comparison of RNFL thickness between the healthy controls and MS eyes showed a statistically thinner RNFL in the MS group in average thickness and the 4 quadrants (p < 0.0001), except for the nasal quadrant (p = 0.079) ( Table 2) .
Comparison of the PPCT in the four zones between the healthy controls and MS eyes revealed a statistically thinner Fig. 1 . On the left, image of the 26 9 26 cube-grid centred in the optic disc of a right eye obtained with Deep Range Imaging (DRI) optical coherence tomography (OCT) Triton (Topcon Corporation, Tokio, Japan). This grid includes 676 cubes of 200 lm around the optic disc: the 88 central cubes corresponding to the optic disc area are not measured, and DRI-OCT Triton automatically displays choroidal thickness in each of the 588 peripapillary cubes. The selected cube marked in this example corresponds with the row number 7 and file number 14. On the right, schematic representation of the four zones defined in the 26 9 26 cube-grid using the peripapillary choroidal thickness measurements in the teaching control population: Zone 1 corresponds with optic nerve head and is represented in grey; zone 2 corresponds with peripapillary choroidal thickness means between 120 and 179 lm, and is represented in orange; zone 3 corresponds with mean peripapillary choroidal thickness between 180 and 239 lm, and is represented in green; and zone 4 corresponds with mean peripapillary choroidal thickness ≥ 240 lm, and is represented in purple. Mean choroidal thickness AE standard deviation of each zone was evaluated in the three groups (teaching control group, validating control group and multiple sclerosis group).
choroidal layer in the MS group in all zones (p < 0.0001; Table 1 and Fig. 1B) .
Peripapillary choroidal thickness (PPCT) exhibited a similar pattern in controls and MS: thicker in the superior region, followed by the temporal, nasal and inferior regions, as shown in Fig. 3 .
Discussion
The role of the choroid in MS has been unclear, and this is the first study to evaluate this ocular layer in patients with MS compared with healthy controls using automatic measurements. Retinal nerve fibre layer (RNFL) thickness measurements by OCT are considered a useful indirect marker of the progression of brain atrophy in patients with MS (Frohman et al. 2009; Garcia-Martin et al. 2010 , 2013 . D€ orr et al. (2011) demonstrated the utility of monitoring peripapillary RNFL thickness with OCT for predicting the likelihood of increased disability in patients with MS over time and for predicting a decrease in the quality of life. Typical ophthalmic findings in patients with MS are optic nerve atrophy and peripapillary RNFL thinning (Gordon-Lipkin et al. 2007) but the impact of MS on other deeper ocular layers, such as the choroid, has not been established.
In our study, we found that patients with MS present a 22% reduction in choroidal thickness in zone 2, 17% reduction in zone 3, and 15% reduction in zone 4, compared with controls. This mean total decrease of 17.85% in the choroidal thickness of patients with MS may be secondary to a reduction in blood flow subsequent to RNFL atrophy.
The choroid is a dynamic structure whose thickness varies in accordance with several factors: age (Margolis & Spaide 2009; Ehrlich et al. 2011 ), intraocular pressure (Arora et al. 2012) , myopia, and axial length (Fujiwara et al. 2009; Chakraborty et al. 2011) . Therefore, these variables were used as exclusion criteria for the present study. Zhang et al. (2015) suggested that there are several potential reasons for the conflicting OCT findings of PPCT, such as different measurement techniques (most of them manually-performed), and the dynamic and variable nature of the choroid. The development of new technologies such as DRI SS OCTs provide opportunities for better delimitation of the retinal layers and measurements of a huge number of points in peripapillary and further areas of the choroid. These tools allow us to visualize the actual morphology of the choroidal layer and the possible effects of different diseases (Peng et al. 2017) .
Our intention was first to better understand the pattern of PPCT in normal eyes; establish different zones based on the distribution of choroidal thickness and to compare these areas with MS eyes. Some histologic studies Fig. 3 . Three-dimensional graphical representation of the peripapillary choroidal thickness measurements (up) and representation of peripapillary choroidal thickness means in the 26 9 26 cube-grid centred in the optic disc (down) of the three groups of the study: the teaching population, the validating population and the multiple sclerosis patients group. Zone 1 corresponds with the optic nerve head and is represented in yellow; zone 2 corresponds with peripapillary choroidal thickness means between 120 and 179 lm, and is represented in orange; zone 3 corresponds with peripapillary choroidal thickness means between 180 and 239 lm, and is represented in green; and zone 4 corresponds with peripapillary choroidal thickness means ≥240 lm, and is represented in purple. Number of peripapillary cubes with thickness ≥240 lm 6 104 <0.0001
Comparison of the choroidal thickness in the established four zones in control group and multiple sclerosis patients. Comparison of number of peripapillary cubes with thickness between 120-179 lm; between 180-239 lm and ≥240 lm. Zone 1 corresponds with optic nerve head and was not be included in the analysis. BCVA = best corrected visual acuity; EDSS = expanded disability status scale, MD = mean deviation, MS = multiple sclerosis. * p: level of statistical significance in comparison between the two groups using the Student T-test (except for sex, chi-square test). Data are mean AE standard deviation. Bold text indicates statistically significant results (p < 0.05).
and other studies with SD-OCT demonstrated that the choroid tends to be thinner around the optic nerve head compared with the subfoveal choroid, which is consistent with our results (Ramrattan et al. 1994; Fujiwara et al. 2009; Margolis & Spaide 2009 ). We found that the peripapillary choroid is thicker superiorly and thinner near the optic nerve head, especially inferiorly, in both healthy subjects and patients with MS, consistent with Jiang et al. (2015) ;. The choroidal pattern is the same in patients with MS, but with thinner measurements, as shown in Fig. 3 . We found that the peripapillary choroid was thinner in patients with MS in all zones, and the differences tended to decrease as we moved away from the optic nerve head. This finding is consistent with results of Esen et al. (2016) ; who evaluated 68 eyes of patients with MS and 60 eyes of healthy subjects were evaluated, using manual choroidal measurements at seven points with EDI OCT, and found a decrease in mean subfoveal choroidal thickness in MS group. Li et al. (2013) studied choroidal thickness using a 360°3.4-mm scan circle centred on the optic nerve head in 31 glaucoma patients and 31 healthy controls and found no significant differences. Ehrlich et al. (2011) also found no association between RNFL thickness and PPCT in glaucoma patients and glaucoma suspects. The imaging devices used in these previous studies, however, do not automatically segment the choroid, making manual calculations subjective to the operator 0 s error; and they only analyzed a circle scan, not a wide area of choroid such as in our study. The SS-OCT used by these authors only evaluates 12 central degrees around the optic nerve and reports discrete manual measurements of the choroidal thickness in this small area, while the DRI-OCT used in our study provides a total of 588 automatic measurements of the choroidal thickness in a broader area around the optic nerve (a square area of 5.2 9 5.2 mm, that corresponds to~20 central degrees). On the other hand, our choroidal measurements were automatic and did not depend on the observer or on potential errors in manual delimitation, making them more objective, reproducible and accurate. Peng et al. (2017) used SD-OCT automated segmentation to distinguish between eyes of patients with one episode of optic neuritis and patients with neuromyelitis, but they did not measure choroid.
Our results revealed that optic atrophy in MS eyes may cause the consequent reduction in blood flow in the optic nerve and neuroretinal structures, so we can intuit the following physiopathological cascade: axonal damage in the RNFL caused by MS neurodegeneration -blood flow decrease in the neuroretina -choroidal thinning (because choroid is a highly vascularized tissue) -more axonal damage in the RNFL caused by ischaemia. Neuroophthalmology researchers have found RNFL thinning in patients with MS, even when they do not have disease progression (EDSS and MSQOL stable) or MS relapses (Garcia-Martin et al. 2011 , 2013 Martinez-Lapiscina et al. 2016) . The progressive RNFL thinning in these patients may be explained by this ischaemic mechanism of action that would damage the optic nerve, similar to normotensive glaucoma with ischaemic component (Svr cinov a et al. 2017) . Thus, the potential clinical applications of our findings would be to identify MS patients with higher ischaemic component, to improve the blood flow in the optic nerve and delay or stop the RNFL and choroidal thinning (Bathija 2000) . Clinical trials are currently in progress for the treatment of normotensive glaucoma, with methods that increase blood flow in the optic nerve, such as medications that inhibit spasm of the vessels to the eye or that raise systemic blood pressure, removing the plaque in the carotid artery if it exists, or using a catheter with a balloon inserted through the artery in plaques located in smaller or harder-to-reach areas, or using Rho-associated coiled coil-forming protein kinase (ROCK) inhibitors (Y-27632 and Y39983) to relax rabbit ciliary arteries (Watabe et al. 2011) .
Several methods have been used to measure blood flow in the optic nerve head, and may be useful to evaluate the accuracy of this ischaemic theory in the optic nerve of patients with MS: colour Doppler ultrasound imaging, confocal tomographic angiography, Heidelberg retinal flowmeter -HRF-(a confocal scanning laser device, which utilises the Doppler effect) (Bathija 2000) . More studies using these techniques may provide information about physiopathological procedures in MS disease.
Histologic findings of the choroid are contradictory in studies of Yin et al. (1997) and Spraul et al. (2002) . Our findings suggest that choroidal measurements with SS-OCT provide useful information, especially in cases in which common functional and structural tests do not provide consistent results.
In addition, we have found statistical reduction of BCVA and MD of the visual field in patients with MS, suggesting that even MS eyes without optic neuritis antecedent, present subclinical visual path affectation (GarciaMartin et al. 2013) . This visual path atrophy may be involved in the physiopathological mechanism of choroidal thinning in patients with MS (Satue et al. 2018 ).
The present study has several limitations. First, there were no data on axial length in this study; however, there was no significant difference in the refractive error among groups. The axial length and refractive error variables are related, but not interchangeable, as the axial length tends not to change after the second decade of life, except in some cases. The refractive error, however, may fluctuate or change due to different factors (Chen et al. 2012 ). The (Tan et al. 2012) and in the present study, we did not perform OCT examinations at the same time of day in all participants, although all OCT scans were acquired in the evening (between 16:00 and 20:00 hr). Third, we only measured choroidal thickness in the right eyes of each participant, and inter-eye differences were not assessed. Fourth, the patients with MS were not divided according to severity. Studies of the potential association between PPCT and MS severity and effects on the quality of life, or between PPCT and peripapillary RNFL thickness might produce interesting results. Finally, the reliability of automated choroidal thickness measurements obtained with this new SS-OCT is not yet established and should be confirmed in future studies.
In conclusion, the present study demonstrated a significant association between choroidal thickness in different zones of the retinal tissue around the optic disc and the presence of MS. Although these associations are statistically significant in all zones around the optic nerve, the association was higher in the area nearest the optic disc. The peripapillary choroidal tissue exhibits a similar pattern in healthy and MS eyes (thickest superiorly and thinnest inferiorly), but in MS eyes the PPCT is thinner than that in healthy eyes in all zones. More studies of choroidal thickness changes based on new technologies would help to elucidate the potential role of this evaluation in clinical practice.
